Insider · CIK 0002122447

Smith Darren Charlton

Reports to the SEC for 1 company · NORTH MELBOURNE

Transactions

Companies

Filings

CIK

0002122447

Forms 4 and 5

Insider transactions

3 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-07	TLXTelix Pharmaceuticals LtdP Purchase	Group Chief Financial Officer	PPurchase	+2,071 sh	$9.66	+$20K	13,992
2026-03-29	TLXTelix Pharmaceuticals LtdM Exercise/Conversion	Group Chief Financial Officer	MExercise/Conversion	+1,111 sh	—	—	11,921
2026-03-29	TLXTelix Pharmaceuticals Ltd · Share RightsM Exercise/Conversion	Group Chief Financial Officer	MExercise/Conversion	−1,111 sh	—	—	0

C/O TELIX PHARMACEUTICALS LTD 55 FLEMINGTON RD

NORTH MELBOURNE, 3051